CD8A and neoplasm: Furthermore, SLC2A3 also known as a glucose transporter was upregulated in tumour‐infiltrating CD8+ T cells and negatively associated with the proliferation and function of CD8+ T cells via potentially driving CD8+ T‐cell ferroptosis.159